LYMPHOPROLIFERATIVE DISEASE
Clinical trials for LYMPHOPROLIFERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISEASE trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune cells take aim at Virus-Linked lymphomas
Disease control Recruiting nowThis study tests a new way to make immune cells (called GRALE T cells) that are trained to attack cells infected with the Epstein-Barr virus (EBV), which is linked to some lymphomas. The trial includes people with Hodgkin or non-Hodgkin lymphoma, or related diseases, whose cancer…
Matched conditions: LYMPHOPROLIFERATIVE DISEASE
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Massive 10-Year registry launches to unlock secrets of blood cancers
Knowledge-focused Recruiting nowThis study is a large registry that will follow 9,000 adults with lymphoproliferative disorders (a type of blood cancer) for up to 10 years. Researchers aim to learn how long people live, how different treatments work, and what factors affect the disease. No new treatments are gi…
Matched conditions: LYMPHOPROLIFERATIVE DISEASE
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC